| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Chief Development Officer
1 company
Yea Christopher is a Chief Development Officer at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $6.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,601 | $9.82 | $25,552.74 | -2.7% | +23.4% | +58.0% | |
| Nov 26, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,963 | $9.87 | $19,378.34 | -2.1% | +3.8% | +41.3% | |
| Nov 18, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,192 | $9.26 | $66,572.75 | -7.4% | +5.2% | +53.4% | |
| Aug 23, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,916 | $12.40 | $23,758.40 | -2.2% | -26.2% | +6.2% | |
| Aug 19, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,102 | $12.01 | $85,318.46 | -7.8% | -24.0% | +4.7% | |
| May 20, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 11,610 | $11.76 | $136,585.85 | -12.7% | +3.0% | +3.0% | |
| Feb 20, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 12,053 | $14.11 | $170,124.48 | -14.2% | -13.9% | -22.4% | |
| Feb 14, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 39,886 | $15.01 | $598,660.94 | -37.6% | -13.3% | -33.8% | |
| Nov 20, 2023 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,113 | $8.23 | $58,535.01 | -13.4% | +68.1% | +10.2% | |
| Aug 18, 2023 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,142 | $10.73 | $76,624.38 | -14.6% | -29.4% | +11.3% |